Lux Health Tech Acquisition Corp. Announces Closing of $345 Million Initial Public Offering
October 29 2020 - 2:05PM
Business Wire
Lux Health Tech Acquisition Corp. (the “Company”) announced
today the closing of its initial public offering of 34,500,000
units, which included the full exercise of the underwriters’
over-allotment option, at a price of $10.00 per unit, resulting in
gross proceeds of $345,000,000. The units began trading on the
Nasdaq Stock Market, LLC (“Nasdaq”) under the ticker symbol “LUXAU”
on October 27, 2020. Each unit issued in the offering consists of
one share of the Company’s Class A common stock and one-third of
one warrant, each whole warrant entitling the holder thereof to
purchase one share of Class A common stock at an exercise price of
$11.50 per share. After the securities comprising the units begin
separate trading, the shares of Class A common stock and warrants
are expected to be listed on Nasdaq under the symbols “LUXA” and
“LUXAW,” respectively. No fractional warrants will be issued upon
separation of the units and only whole warrants will trade.
Credit Suisse Securities (USA) LLC served as the sole book
runner for the offering and Stifel, Nicolaus & Company,
Incorporated acted as lead manager.
The offering was made only by means of a prospectus. Copies of
the prospectus may be obtained from Credit Suisse Securities (USA)
LLC, Attn: Prospectus Department, 6933 Louis Stephens Drive,
Morrisville, North Carolina 27560, United States, Telephone:
1-800-221-1037, Email: usa.prospectus@credit-suisse.com.
A registration statement relating to these securities has been
filed with the Securities and Exchange Commission (“SEC”) and
became effective on October 26, 2020. This press release shall not
constitute an offer to sell or the solicitation of an offer to buy,
nor shall there be any sale of these securities in any state or
jurisdiction in which such an offer, solicitation or sale would be
unlawful prior to registration or qualification under the
securities laws of any such state or jurisdiction.
ABOUT LUX HEALTH TECH ACQUISITION CORP.
Lux Health Tech Acquisition Corp. is a blank check company
sponsored by an affiliate of Lux Capital and formed for the purpose
of entering into a merger, capital stock exchange, asset
acquisition, stock purchase, reorganization or similar business
combination with one or more businesses at the intersection of the
healthcare and technology industries.
FORWARD-LOOKING STATEMENTS
This press release contains statements that constitute
“forward-looking statements.” Forward-looking statements are
subject to numerous conditions, many of which are beyond the
control of the Company, including those set forth in the Risk
Factors section of the Company’s registration statement and
prospectus for the offering filed with the SEC. Copies are
available on the SEC’s website, www.sec.gov. The Company undertakes
no obligation to update these statements for revisions or changes
after the date of this release, except as required by law.
View source
version on businesswire.com: https://www.businesswire.com/news/home/20201029006094/en/
Investors: Scott Rubin Email:
scott.rubin@luxcapital.com
Lux Health Tech Acquisit... (NASDAQ:LUXAU)
Historical Stock Chart
From Sep 2024 to Oct 2024
Lux Health Tech Acquisit... (NASDAQ:LUXAU)
Historical Stock Chart
From Oct 2023 to Oct 2024